FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation

PMA: P100010 · Supplement: S082 · Decision Sep 25, 2018
Classifications
1
FEI Numbers
61
Registration Numbers
61

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
Trade Name
Arctic Front Advance Cardiac Cryoablation Catheter
PMA Number
P100010
Supplement Number
S082
Device Class
FDA Class 3
Product Code
OAE
Generic Name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
September 25, 2018
Date Received
August 27, 2018
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Addition of a new manufacturing line for the Arctic Front Advance Cardiac Cryoablation catheter.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAE Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation